CapMan Infra, through its Nordic Infrastructure II fund, has acquired a majority stake in ProPellet Oy, Finland’s leading ...

An EUR 84 million investment will fund the development of two photovoltaic solar plants with integrated battery energy ...

OMRON Healthcare has secured De Novo authorisation from the US Food and Drug Administration (FDA) for new home blood pressure ...

OMRON Healthcare has received de novo authorization from the U.S. Food and Drug Administration (FDA) to market new home blood pressure monitors featuring AI-powered atrial fibrillation ...

In a pivotal stride to address the growing AFib epidemic, OMRON Healthcare today announced the U.S. Food and Drug ...

The FDA has granted a de novo clearance to a wearable device—with a form factor you’re familiar with—that can check patients ...

OMRON offers an array of products, including OMRON Complete, which combines blood pressure monitoring with ECG to detect heart irregularities like AFib, tachycardia, and hypertension. Through the ...

Founded by Kazuma Tateishi, OMRON’s mission has always been about empowering people to take charge of their health. The company has spent over 50 years developing innovative solutions for ...

Atrial fibrillation (AFib) is an irregular and often rapid heart rhythm. The terms “controlled AFib” and “uncontrolled AFib” describe whether treatment strategies are effectively managing ...

GREENVILLE, N.C. (WNCT) — ECU Health is introducing a new procedure to treat Atrial Fibrillation. The procedure is called “Farapulse,” first performed on a patient at ECU Health about three ...

Report Ocean has published a new report on the Atrial Fibrillation Market, delivering an extensive analysis of key factors such as market restraints, drivers, and opportunities. The report offers a ...